Role of the CCN protein family in cancer
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
The CCN protein family is composed of six matricellular proteins, which serve regulatory roles rather than structural roles in the extracellular matrix. First identified as secreted proteins which are induced by oncogenes, the acronym CCN came from the names of the first three members: CYR61, CTGF, and NOV. All six members of the CCN family consist of four cysteine-rich modular domains. CCN proteins are known to regulate cell adhesion, proliferation, differentiation, and apoptosis. In addition, CCN proteins are associated with cardiovascular and skeletal development, injury repair, inflammation, and cancer. They function either through binding to integrin receptors or by regulating the expression and activity of growth factors and cytokines. Given their diverse roles related to the pathology of certain diseases such as fibrosis, arthritis, atherosclerosis, diabetic nephropathy, retinopathy, and cancer, there are many emerging studies targeting CCN protein signaling pathways in attempts to elucidate their potentials as therapeutic targets.
Abstract
The CCN protein family is composed of six matricellular proteins, which serve regulatory roles rather than structural roles in the extracellular matrix. First identified as secreted proteins which are induced by oncogenes, the acronym CCN came from the names of the first three members: CYR61, CTGF, and NOV. All six members of the CCN family consist of four cysteine-rich modular domains. CCN proteins are known to regulate cell adhesion, proliferation, differentiation, and apoptosis. In addition, CCN proteins are associated with cardiovascular and skeletal development, injury repair, inflammation, and cancer. They function either through binding to integrin receptors or by regulating the expression and activity of growth factors and cytokines. Given their diverse roles related to the pathology of certain diseases such as fibrosis, arthritis, atherosclerosis, diabetic nephropathy, retinopathy, and cancer, there are many emerging studies targeting CCN protein signaling pathways in attempts to elucidate their potentials as therapeutic targets.
참고문헌 (91)
- Aszodi A, "What mouse mutants teach us about extracellular matrix function", Annu Rev Cell Dev Biol, 22, pp.591~621 (2006)[DOI]
- Bornstein P, "Matricellular proteins: extracellular modulators of cell function", Curr Opin Cell Biol, 14, pp.608~616 (2002)[DOI]
- Jun JI, "Taking aim at the extracellular matrix: CCN proteins as emerging therapeutic targets", Nat Rev Drug Discov, 10, pp.945~963 (2011)[DOI]
- Joliot V, "Proviral rearrangements and overexpression of a new cellular gene (nov) in myeloblastosis-associated virus type 1-induced nephroblastomas", Mol Cell Biol, 12, pp.10~21 (1992)[DOI]
- O'Brien TP, "Expression of cyr61, a growth factor-inducible immediateearly gene", Mol Cell Biol, 10, pp.3569~3577 (1990)[DOI]
- Bradham DM, "Connective tissue growth factor: a cysteine-rich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10", J Cell Biol, 114, pp.1285~1294 (1991)[DOI]
- Holbourn KP, "The CCN family of proteins: structure-function relationships", Trends Biochem Sci, 33, pp.461~473 (2008)[DOI]
- Leask A, "All in the CCN family: essential matricellular signaling modulators emerge from the bunker", J Cell Sci, 119, pp.4803~4810 (2006)[DOI]
- Perbal BV, "CCN proteins : a new family of cell growth and differentiation regulators" (2005), Imperial College Press
- Fukunaga-Kalabis M, "CCN3 controls 3D spatial localization of melanocytes in the human skin through DDR1", J Cell Biol, 175, pp.563~569 (2006)[DOI]
- Chen CC, "The angiogenic factors Cyr61 and connective tissue growth factor induce adhesive signaling in primary human skin fibroblasts", J Biol Chem, 276, pp.10443~10452 (2001)[DOI]
- Grzeszkiewicz TM, "CYR61 stimulates human skin fibroblast migration through Integrin alpha vbeta 5 and enhances mitogenesis through integrin alpha vbeta 3, independent of its carboxyl-terminal domain", J Biol Chem, 276, pp.21943~21950 (2001)[DOI]
- Gao R, "A novel integrin alpha5beta1 binding domain in module 4 of connective tissue growth factor (CCN2", CTGF) promotes adhesion and migration of activated pancreatic stellate cells, 2006, pp.55, 856~862
- Babic AM, "Fisp12", mouse connective tissue growth factor mediates endothelial cell adhesion and migration through integrin alphavbeta3, promotes endothelial cell survival, and induces angiogenesis in vivo, 1999, pp.19, 2958~2966
- Soon LL, "Overexpression of WISP-1 down-regulated motility and invasion of lung cancer cells through inhibition of Rac activation", J Biol Chem, 278, pp.11465~11470 (2003)[DOI]
- Lake AC, "CCN5 is a growth arrest-specific gene that regulates smooth muscle cell proliferation and motility", Am J Pathol, 162, pp.219~231 (2003)[DOI]
- Lau LF, "The CCN family of angiogenic regulators: the integrin connection", Exp Cell Res, 248, pp.44~57 (1999)[DOI]
- Perbal B, "NOV (nephroblastoma overexpressed) and the CCN family of genes: structural and functional issues", Mol Pathol, 54, pp.57~79 (2001)[DOI]
- Fan WH, "Connective tissue growth factor (CTGF) stimulates vascular smooth muscle cell growth and migration in vitro", Eur J Cell Biol, 79, pp.915~923 (2000)[DOI]
- Grzeszkiewicz TM, "The angiogenic factor cysteine-rich 61 (CYR61, CCN1) supports vascular smooth muscle cell adhesion and stimulates chemotaxis through integrin alpha(6)beta(1) and cell surface heparan sulfate proteoglycans", Endocrinology, 143, pp.1441~1450 (2002)[DOI]
- Shimoyama T, "CCN3 inhibits neointimal hyperplasia through modulation of smooth muscle cell growth and migration", Arterioscler Thromb Vasc Biol, 30, pp.675~682 (2010)[DOI]
- Yosimichi G, "CTGF", Hcs24 induces chondrocyte differentiation through a p38 mitogen-activated protein kinase (p38MAPK), and proliferation through a p44, extracellular-signal regulated kinase (ERK), pp.Eur J Biochem, 2001[DOI]
- Zuo GW, "The CCN proteins: important signaling mediators in stem cell differentiation and tumorigenesis", Histol Histopathol, 25, pp.795~806 (2010)
- Parisi MS, "Expression and regulation of CCN genes in murine osteoblasts", Bone, 38, pp.671~677 (2006)[DOI]
- Maeda A, "CCN family 2", connective tissue growth factor modulates BMP signalling as a signal conductor, which action regulates the proliferation and differentiation of chondrocytes, 2009, pp.145, 207~216
- Ono M, "WISP-1", CCN4 regulates osteogenesis by enhancing BMP-2 activity, 2011, pp.26, 193~208
- Kubota S, "CCN family proteins and angiogenesis: from embryo to adulthood", Angiogenesis, 10, pp.1~11 (2007)[DOI]
- Babic AM, "CYR61, a product of a growth factor-inducible immediate early gene, promotes angiogenesis and tumor growth", Proc Natl Acad Sci U S A, 95, pp.6355~6360 (1998)[DOI]
- Lin CG, "CCN3 (NOV) is a novel angiogenic regulator of the CCN protein family", J Biol Chem, 278, pp.24200~24208 (2003)[DOI]
- Shimo T, "Connective tissue growth factor induces the proliferation, migration, and tube formation of vascular endothelial cells in vitro, and angiogenesis in vivo", J Biochem, 126, pp.137~145 (1999)[DOI]
- Fataccioli V, "Stimulation of angiogenesis by Cyr61 gene: a new therapeutic candidate", Hum Gene Ther, 13, pp.1461~1470 (2002)[DOI]
- Inoki I, "Connective tissue growth factor binds vascular endothelial growth factor (VEGF) and inhibits VEGF-induced angiogenesis", FASEB J, 16, pp.219~221 (2002)[DOI]
- Nathans D, "Genomic response to growth factors", Cold Spring Harb Symp Quant Biol, 53, pp.893~900 (1988)[DOI]
- Grotendorst GR, "Connective tissue growth factor: a mediator of TGF-beta action on fibroblasts", Cytokine Growth Factor Rev, 8, pp.171~179 (1997)[DOI]
- Lin CG, "Integrin-dependent functions of the angiogenic inducer NOV (CCN3): implication in wound healing", J Biol Chem, 280, pp.8229~8237 (2005)[DOI]
- Dhar A, "The CCN family proteins in carcinogenesis", Exp Oncol, 32, pp.2~9 (2010)
- Perbal B, "The CCN family of genes: a brief history", Mol Pathol, 54, pp.103~104 (2001)[DOI]
- Bleau AM, "CCN proteins and cancer: two to tango", Front Biosci, 10, pp.998~1009 (2005)[DOI]
- Perbal B, "NOV story: the way to CCN3", Cell Commun Signal, 4, pp.3~ (2006)[DOI]
- Gery S, "Ovarian carcinomas: CCN genes are aberrantly expressed and CCN1 promotes proliferation of these cells", Clin Cancer Res, 11, pp.7243~7254 (2005)[DOI]
- Lv H, "Cyr61 is up-regulated in prostate cancer and associated with the p53 gene status", J Cell Biochem, 106, pp.738~744 (2009)[DOI]
- Watari H, "Cyr61, a member of ccn (connective tissue growth factor", cysteine-rich 61, Gynecol Oncol, pp.2009, 112[DOI]
- Planque N, "A structural approach to the role of CCN (CYR61", CTGF, Cancer Cell Int, pp.2003, 3[DOI]
- Schmitz P, "Cyr61", CCN1 affects the integrin-mediated migration of prostate cancer cells (PC-3) in vitro, 2013, pp.51, 47~50
- Tsai MS, "Expression and function of CYR61, an angiogenic factor, in breast cancer cell lines and tumor biopsies", Cancer Res, 60, pp.5603~5607 (2000)
- Xie D, "Cyr61 is overexpressed in gliomas and involved in integrin-linked kinasemediated Akt and beta-catenin- TCF", Lef signaling pathways, 2004, pp.64, 1987~1996
- Chen PP, "Expression of Cyr61, CTGF, and WISP-1 correlates with clinical features of lung cancer", PLoS One, 2, pp.e534~ (2007)[DOI]
- Maeta N, "CYR61 downregulation correlates with tumor progression by promoting MMP-7 expression in human gastric carcinoma", Oncology, 73, pp.118~126 (2007)[DOI]
- Chien W, "Cyr61 suppresses growth of human endometrial cancer cells", J Biol Chem, 279, pp.53087~53096 (2004)[DOI]
- Croci S, "Expression of connective tissue growth factor (CTGF", CCN2) in a mouse model of rhabdomyosarcomagenesis, 2007, pp.13, 336~339
- Deng YZ, "Connective tissue growth factor is overexpressed in esophageal squamous cell carcinoma and promotes tumorigenicity through beta-catenin-T-cell factor", Lef signaling, 2007, pp.282, 36571~36581
- Jiang WG, "Differential expression of the CCN family members Cyr61, CTGF and Nov in human breast cancer", Endocr Relat Cancer, 11, pp.781~791 (2004)[DOI]
- Bennewith KL, "The role of tumor cell-derived connective tissue growth factor (CTGF", CCN2) in pancreatic tumor growth, 2009, pp.69, 775~784
- Shakunaga T, "Expression of connective tissue growth factor in cartilaginous tumors", Cancer, 89, pp.1466~1473 (2000)[DOI]
- Chien W, "Expression of connective tissue growth factor (CTGF", CCN2) in breast cancer cells is associated with increased migration and angiogenesis, 2011, pp.38, 1741~1747
- Kang Y, "A multigenic program mediating breast cancer metastasis to bone", Cancer Cell, 3, pp.537~549 (2003)[DOI]
- Shimo T, "Pathogenic role of connective tissue growth factor (CTGF", CCN2) in osteolytic metastasis of breast cancer, 2006, pp.21, 1045~1059
- Bleau AM, "Antiproliferative activity of CCN3: involvement of the C-terminal module and post-translational regulation", J Cell Biochem, 101, pp.1475~1491 (2007)[DOI]
- Gupta N, "Inhibition of glioma cell growth and tumorigenic potential by CCN3 (NOV)", Mol Pathol, 54, pp.293~299 (2001)[DOI]
- Gellhaus A, "Connexin43 interacts with NOV: a possible mechanism for negative regulation of cell growth in choriocarcinoma cells", J Biol Chem, 279, pp.36931~36942 (2004)[DOI]
- Benini S, "In Ewing's sarcoma CCN3(NOV) inhibits proliferation while promoting migration and invasion of the same cell type", Oncogene, 24, pp.4349~4361 (2005)[DOI]
- Fukunaga-Kalabis M, "Downregulation of CCN3 expression as a potential mechanism for melanoma progression", Oncogene, 27, pp.2552~2560 (2008)[DOI]
- Maillard M, "Differential expression of the ccn3 (nov) proto-oncogene in human prostate cell lines and tissues", Mol Pathol, 54, pp.275~280 (2001)[DOI]
- Manara MC, "The expression of ccn3(nov) gene in musculoskeletal tumors", Am J Pathol, 160, pp.849~859 (2002)[DOI]
- Glukhova L, "Patterns of specific genomic alterations associated with poor prognosis in high-grade renal cell carcinomas", Cancer Genet Cytogenet, 130, pp.105~110 (2001)[DOI]
- Zhang T, "The clinical and prognostic significance of CCN3 expression in patients with cervical cancer", Adv Clin Exp Med, 22, pp.839~845 (2013)
- Pennica D, "WISP genes are members of the connective tissue growth factor family that are up-regulated in wnt-1-transformed cells and aberrantly expressed in human colon tumors", Proc Natl Acad Sci U S A, 95, pp.14717~14722 (1998)[DOI]
- Davies SR, "Differential expression of the CCN family member WISP-1, WISP-2 and WISP-3 in human colorectal cancer and the prognostic implications", Int J Oncol, 36, pp.1129~1136 (2010)
- Xie D, "Elevated levels of connective tissue growth factor, WISP-1, and CYR61 in primary breast cancers associated with more advanced features", Cancer Res, 61, pp.8917~8923 (2001)
- Chuang JY, "Apoptosis signal-regulating kinase 1 is involved in WISP-1-promoted cell motility in human oral squamous cell carcinoma cells", PLoS One, 8, pp.e78022~ (2013)[DOI]
- Hashimoto Y, "Identification of genes differentially expressed in association with metastatic potential of K-1735 murine melanoma by messenger RNA differential display", Cancer Res, 56, pp.5266~5271 (1996)
- Hashimoto Y, "Expression of the Elm1 gene, a novel gene of the CCN (connective tissue growth factor, Cyr61", Cef10, and neuroblastoma overexpressed gene) family, suppresses In vivo tumor growth and metastasis of K-1735 murine melanoma cells, 1998, pp.187, 289~296
- Davies SR, "Differential expression and prognostic implications of the CCN family members WISP-1, WISP-2, and WISP-3 in human breast cancer", Ann Surg Oncol, 14, pp.1909~1918 (2007)[DOI]
- Yu C, "NOV (CCN3) regulation in the growth plate and CCN family member expression in cartilage neoplasia", J Pathol, 201, pp.609~615 (2003)[DOI]
- Mason HR, "The growth arrest-specific gene CCN5 is deficient in human leiomyomas and inhibits the proliferation and motility of cultured human uterine smooth muscle cells", Mol Hum Reprod, 10, pp.181~187 (2004)[DOI]
- Dhar G, "Loss of WISP-2", CCN5 signaling in human pancreatic cancer: a potential mechanism for epithelial-mesenchymal-transition, 2007, pp.254, 63~70
- Kouzu Y, "WISP-2 expression in human salivary gland tumors", Int J Mol Med, 17, pp.567~573 (2006)
- Yang Z, "A comparative study of clinicopathological significance, FGFBP1, and WISP-2 expression between squamous cell", adenosquamous carcinomas and adenocarcinoma of the gallbladder, 2014, pp.19, 325~335
- Tomimaru Y, "Upregulation of T-cell factor-4 isoformresponsive target genes in hepatocellular carcinoma", Liver Int, 33, pp.1100~1112 (2013)[DOI]
- Colli LM, "Components of the canonical and non-canonical Wnt pathways are not mis-expressed in pituitary tumors", PLoS One, 8, pp.e62424~ (2013)[DOI]
- Fritah A, "Role of WISP-2", CCN5 in the maintenance of a differentiated and noninvasive phenotype in human breast cancer cells, 2008, pp.28, 1114~1123
- Banerjee S, "CCN5", WISP-2 expression in breast adenocarcinoma is associated with less frequent progression of the disease and suppresses the invasive phenotypes of tumor cells, 2008, pp.68, 7606~7612
- Kleer CG, "WISP3 is a novel tumor suppressor gene of inflammatory breast cancer", Oncogene, 21, pp.3172~3180 (2002)[DOI]
- Lorenzatti G, "CCN6 (WISP3) decreases ZEB1-mediated EMT and invasion by attenuation of IGF-1 receptor signaling in breast cancer", J Cell Sci, 124, pp.1752~1758 (2011)[DOI]
- Huang W, "Inhibition of CCN6 (Wnt-1-induced signaling protein 3) downregulates E-cadherin in the breast epithelium through induction of snail and ZEB1", Am J Pathol, 172, pp.893~904 (2008)[DOI]
- Thorstensen L, "WNT1 inducible signaling pathway protein 3, WISP-3, a novel target gene in colorectal carcinomas with microsatellite instability", Gastroenterology, 121, pp.1275~1280 (2001)[DOI]
- Chen CC, "Functions and mechanisms of action of CCN matricellular proteins", Int J Biochem Cell Biol, 41, pp.771~783 (2009)[DOI]
- Lau LF, "CCN1", CYR61: the very model of a modern matricellular protein, 2011, pp.68, 3149~3163
- Abreu JG, "Connective-tissue growth factor (CTGF) modulates cell signalling by BMP and TGF-beta", Nat Cell Biol, 4, pp.599~604 (2002)[DOI]
- Nishida T, "Effect of CCN2 on FGF2-induced proliferation and MMP9 and MMP13 productions by chondrocytes", Endocrinology, 152, pp.4232~4241 (2011)[DOI]
- Li J, "Emerging role of CCN family proteins in tumorigenesis and cancer metastasis (Review)", Int J Mol Med, 36, pp.1451~1463 (2015)[DOI]
